For more than twenty years, I have held executive and management roles at some of the world’s leading life science and diagnostic companies. I’m proud to be an accomplished business leader and inventor, specializing in the advancement of life-changing diagnostic technologies. I am currently the Chief Executive Officer of Quantum-Si, The Protein Sequencing Company™, focused on revolutionizing the growing field of proteomics.Prior to joining Quantum-Si, I was the CEO of Truvian Sciences, where I led the evolution of the company’s benchtop blood testing system from a product concept through technology feasibility and into late-stage development. Prior to that, I led the Reproductive and Genetic Health Business Unit at Illumina, Inc., where I oversaw the rapid global growth of next-generation sequencing into new and emerging clinical markets. Earlier in my career, I had a variety of roles across multiple areas for GenMark, Hologic, Third Wave Technologies and Abbott Laboratories.I hold a B.A. in Chemistry with honors from Concordia University and an MBA from Keller Graduate School of Management. I am co-inventor on ten issued or pending patents spanning consumables, instrumentation, optics, manufacturing methods and designs.